FDA Approves New Obesity Drug That Will Compete With Wegovy
The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy.The drug is called tirzepatide and will be sold under the name Zepbound. It…
Read More...
Read More...